| Tuesday, January 6 |
|
3:00 - 7:30 PM
|
Registration
|
Lower Atrium
|
|
6:30 - 7:30 PM
|
Refreshments
|
Lower Atrium
|
|
7:30 - 8:30 PM
|
Keynote Lecture
|
Gallatin
|
|
*
Lee M. Ellis,
University of Texas MD Anderson Cancer Center
|
|
|
|
|
|
*
Luisa Iruela-Arispe,
University of California, Los Angeles
|
|
|
Peter F. Carmeliet,
University of Leuven
Angiogenesis in Cancer
|
|
| Wednesday, January 7 |
|
7:00 - 8:00 AM
|
Breakfast
|
Jefferson/Madison
|
|
8:00 - 11:00 AM
|
Current Clinical Status of Anti-Angiogenic Therapy for Cancer
|
Gallatin
|
|
*
Lee M. Ellis,
University of Texas MD Anderson Cancer Center
Anti-VEGF Therapy: Successes and Failures in the Clinic
|
|
|
Axel Grothey,
Mayo Clinic College of Medicine
Clinical Toxicities of Anti-VEGF Therapy - Focus on Bevacizumab
|
|
|
John V. Heymach,
University of Texas MD Anderson Cancer Center
Circulating Endothelial Precursors as Surrogate Markers of Activity of Anti-VEGF Therapy
|
|
|
|
|
|
Emile E. Voest,
University Medical Center Utrecht
Short Talk: Kinetics of Endothelial (Progenitor) Cell Release from the Bone Marrow in Patients Receiving Chemotherapy Predicts Response and Survival
|
|
|
|
|
|
Mark A. Rosen,
University of Pennsylvania
Non-Invasive Imaging of the Tumor Vascular Phenotype in Humans Undergoing Anti-Vascular and Anti-Angiogenic Therapies
|
|
|
9:20 - 9:40 AM
|
Coffee Break
|
Lower Atrium
|
|
11:00 AM - 5:00 PM
|
On Own for Lunch
|
|
|
11:00 AM - 1:00 PM
|
Poster Setup
|
Jefferson/Madison
|
|
1:00 - 10:00 PM
|
Poster Viewing
|
Jefferson/Madison
|
|
4:30 - 5:00 PM
|
Coffee Available
|
Lower Atrium
|
|
5:00 - 7:00 PM
|
Abnormalities of the Tumor Microvascular Network
|
Gallatin
|
|
*
Luisa Iruela-Arispe,
University of California, Los Angeles
|
|
|
Laura E. Benjamin,
Beth Israel Deaconess Medical Center
Akt Signaling in the Tumor Microenvironment
|
|
|
David A. Cheresh,
University of California, San Diego
A Role for VEGF as a Negative Regulator of Pericyte Function and Vessel Maturation
|
|
|
|
|
|
Ombretta Salvucci,
National Cancer Institute, National Institutes of Health
Short Talk: Requirement for EphrinB Activation in Mural Cells Association with Endothelial Cells during New Vessel Formation
|
|
|
Robert S. Kerbel,
Sunnybrook Health Sciences Centre
Rapid Systemic Induction of Proangiogenic/Vasculogenic Factors by Chemotherapy or Antiangiogenic Drugs: Implications for Tumor Progression and Response to Therapy
|
|
|
7:00 - 8:00 PM
|
Social Hour w/ Lite Bites
|
Jefferson/Madison
|
|
7:30 - 10:00 PM
|
Poster Session 1
|
Jefferson/Madison
|
| Thursday, January 8 |
|
7:00 - 8:00 AM
|
Breakfast
|
Jefferson/Madison
|
|
8:00 - 11:00 AM
|
Tumor Angiogenesis, Inflammation and the Microenvironment
|
Gallatin
|
|
*
Laura E. Benjamin,
Beth Israel Deaconess Medical Center
|
|
|
Luisa Iruela-Arispe,
University of California, Los Angeles
Intracrine VEGF Signaling and Tumor Growth
|
|
|
|
|
|
Raymond N. DuBois,
University of Texas MD Anderson Cancer Center
Inflammatory Mediators and Tumor Progression
|
|
|
|
|
|
Kristian Pietras,
Karolinska Institutet
Exploring New Strategies to Target the Pro-Angiogenic Tumor Stroma
|
|
|
Calvin Kuo,
Stanford University
Short Talk: Angiogenic Phenotypes of the Egfl7 Locus are Attributable to the Embedded MicroRNA miR-126
|
|
|
J. Silvio Gutkind,
National Institutes of Health
Semaphorin-Regulated Signaling Networks and Tumor-Induced Angiogenesis
|
|
|
9:20 - 9:40 AM
|
Coffee Break
|
Lower Atrium
|
|
11:00 AM - 5:00 PM
|
On Own for Lunch
|
|
|
11:00 AM - 1:00 PM
|
Poster Setup
|
Jefferson/Madison
|
|
1:00 - 10:00 PM
|
Poster Viewing
|
Jefferson/Madison
|
|
4:30 - 5:00 PM
|
Coffee Available
|
Lower Atrium
|
|
5:00 - 7:00 PM
|
Vascular Stem and Progenitor Cells
|
Gallatin
|
|
*
Robert S. Kerbel,
Sunnybrook Health Sciences Centre
|
|
|
Richard J. Gilberston,
St Jude Children's Research Hospital
The Perivascular Niche for Tumor Stem Cells
|
|
|
Robert Benezra,
Memorial Sloan-Kettering Cancer Center
Id Proteins and Vascular Mobilization
|
|
|
Avner Adini,
Children's Hospital, Boston
Short Talk: Prominin-1/CD133, is More than a Marker of Premature Hematopoietic Cells
|
|
|
M. Celeste Simon,
University of Pennsylvania
Hypoxia, HIF and Stem Cells
|
|
|
7:00 - 8:00 PM
|
Social Hour w/ Lite Bites
|
Jefferson/Madison
|
|
7:30 - 10:00 PM
|
Poster Session 2
|
Jefferson/Madison
|
| Friday, January 9 |
|
7:00 - 8:00 AM
|
Breakfast
|
Jefferson/Madison
|
|
8:00 - 11:00 AM
|
Tumor Lymphangiogenesis
|
Gallatin
|
|
*
Robert Benezra,
Memorial Sloan-Kettering Cancer Center
|
|
|
Barbara H. Garmy-Susini,
University of California, San Diego
Central Requirement for Integrin Signaling in Lymphangiogenesis and Metastasis
|
|
|
|
|
|
Michael J. Detmar,
ETH - Zürich
Molecular Control of Lymphangiogenesis
|
|
|
Peter Friedl,
NCMLS, Radboud University Nijmegen Medical Centre
Collective Invasion and Radioresistance at the Tumor-Vessel Interface
|
|
|
|
|
|
Yusuke Mizukami,
Asahikawa Medical College
Short Talk: Hedgehog Signaling Regulates Angiogenesis in Pancreatic Cancer
|
|
|
Tuomas Tammela,
University of Helsinki
VEGFR-3 Pathway as a Target to Inhibit Angiogenesis, Lymphangiogenesis and Tumor Metastasis
|
|
|
|
|
|
9:20 - 9:40 AM
|
Coffee Break
|
Lower Atrium
|
|
11:00 AM - 5:00 PM
|
On Own for Lunch
|
|
|
11:00 AM - 1:00 PM
|
Poster Setup
|
Jefferson/Madison
|
|
1:00 - 10:00 PM
|
Poster Viewing
|
Jefferson/Madison
|
|
4:30 - 5:00 PM
|
Coffee Available
|
Lower Atrium
|
|
5:00 - 7:00 PM
|
Imaging Angiogenesis: Histopathologic and Non-Invasive Imaging of Live Animals
|
Gallatin
|
|
Jan E. Schnitzer,
Proteogenomics Research Institute for Systems Medicine (PRISM)
Proteomic Imaging of Tumor Microenvironment and Angiogenesis in vivo for Enhancing Targeted Therapies
|
|
|
|
|
|
|
|
|
Myunghwan Choi,
Korea Advanced Institute of Science and Technology
Short Talk: Dynamic Fluorescence Imaging for Multiparametric Measurement of Tumor Vasculature
|
|
|
|
|
|
Lily Wu,
University of California, Los Angeles
Functional Molecular Imaging of Prostate Cancer Lymphatic Metastasis
|
|
|
*
Donald M. McDonald,
University of California, San Francisco
Imaging of Cellular Actions of Angiogenesis Inhibitors
|
|
|
7:00 - 8:00 PM
|
Social Hour w/ Lite Bites
|
Jefferson/Madison
|
|
7:30 - 10:00 PM
|
Poster Session 3
|
Jefferson/Madison
|
| Saturday, January 10 |
|
7:00 - 8:00 AM
|
Breakfast
|
Jefferson/Madison
|
|
8:00 - 11:00 AM
|
Emerging Targets and Endothelial Cell Biology
|
Gallatin
|
|
*
Gregory D. Plowman,
Genentech
|
|
|
Richard O. Hynes,
Massachusetts Institute of Technology
Cell-Matrix Interactions in Vascular Development
|
|
|
Hellmut G. Augustin,
German Cancer Research Center (DKFZ) & University of Heidelberg
Angiopoietins and Tie-2
|
|
|
Beverly A. Teicher,
Genzyme Corporation
Endosialin/CD248: The Evolution of a Target
|
|
|
Napoleone Ferrara,
Genentech, Inc.
Myeloid Dependent Tumor Angiogenesis and Bv8
|
|
|
|
|
|
9:20 - 9:40 AM
|
Coffee Break
|
Lower Atrium
|
|
11:00 AM - 5:00 PM
|
On Own for Lunch
|
|
|
4:30 - 5:00 PM
|
Coffee Available
|
Lower Atrium
|
|
5:00 - 7:00 PM
|
Notch Signaling
|
Gallatin
|
|
*
Jan K. Kitajewski,
Columbia University
Notch Signaling in Tumor Angiogenesis
|
|
|
Nicholas W. Gale,
Regeneron Pharmaceuticals Inc.
Targeting Tumor Microvasculature via the VEGF and Delta/Notch Pathways
|
|
|
|
|
|
Ji-Liang Li,
Weatherall Institute of Molecular Medicine, University of Oxford
Short Talk: DLL4 Enhances Tumour Growth and Mediates Tumour Resistance to Anti-VEGF Therapy in vivo
|
|
|
Gregory D. Plowman,
Genentech
Contrasting Roles of VEGF and DLL4 in Vascular Biology
|
|
|
7:00 - 8:00 PM
|
Social Hour w/ Lite Bites
|
Jefferson/Madison
|
|
8:00 - 11:00 PM
|
Entertainment
|
Jefferson/Madison
|
| Sunday, January 11 |
|
|
Departure
|
|
